EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

Diabetes - GeneralType 2 DiabetesObesity and Bariatric Surgery

Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study

Diabetologia.

Eriksson JW, Lundkvist P, Jansson PA, Johansson L, Kvarnström M, Moris L, Miliotis T, Forsberg GB, Risérus U, Lind L, Oscarsson J

doi: 10.1007/s00125-018-4675-2.

COMMENTED

Type 2 DiabetesPediatric Diabetes

Non-alcoholic fatty liver disease in pediatric type 2 diabetes: metabolic and histologic characteristics in 38 subjects

Pediatr Diabetes.

Newfield RS, Graves CL, Newbury RO, Schwimmer JB, Proudfoot JA, Say DS, Feldstein AE

doi: 10.1111/pedi.12798.

Diabetes - GeneralType 2 Diabetes

Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes

Metabolism.

Käräjämäki AJ, Bloigu R, Kauma H, Kesäniemi YA, Koivurova OP, Perkiömäki J, Huikuri H, Ukkola O

doi: 10.1016/

Obesity and Bariatric Surgery

Laparoscopic sleeve gastrectomy reverses non-alcoholic fatty liver disease modulating oxidative stress and inflammation

Metabolism.

Cabré N, Luciano-Mateo F, Fernández-Arroyo S, Baiges-Gayà G, Hernández-Aguilera A, Fibla M, Fernández-Julià R, París M, Sabench F, Del Castillo D, Menéndez JA, Camps J, Joven J

doi: 10.1016/j.metabol.

Type 2 DiabetesLipids

Association between non-alcoholic fatty liver disease and impaired cardiac sympathetic/parasympathetic balance in subjects with and without type 2 diabetes-The Cooperative Health Research in South Tyrol (CHRIS)-NAFLD sub-study

Nutr Metab Cardiovasc Dis

Targher G, Mantovani A, Grander C, Foco L, Motta B, Byrne CD, Pramstaller PP, Tilg H

doi: 10.1016/j.numecd.2021.08.037

Diabetes - GeneralLipids

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE

Endocr Pract.

Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, Grunberger G, Guerin CK, Bell DSH, Mechanick JI, Pessah-Pollack R, Wyne K, Smith D, Brinton EA, Fazio S, Davidson M

doi: 10.4158/EP171764.APPGL.

Benign Prostatic Hyperplasia, Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: Is Metaflammation the Link?

Prostate.

Russo GI, Cimino S, Castelli T, Favilla V, Gacci M, Carini M, Condorelli RA, La Vignera S, Calogero AE, Motta F, Puzzo L, Caltabiano R, Morgia G

doi: 10.1002/pros.23237.

Diabetes - GeneralType 2 Diabetes

Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis

Diabetes Care.

Mantovani A, Byrne CD, Bonora E, Targher G

doi: 10.2337/dc17-1902.

RECOMMENDED

Obesity and Bariatric Surgery

Clinical Practice Guidelines for Childbearing Female Candidates for Bariatric Surgery, Pregnancy, and Post-partum Management After Bariatric Surgery

Obes Surg.

Ciangura C, Coupaye M, Deruelle P, Gascoin G, Calabrese D, Cosson E, Ducarme G, Gaborit B, Lelièvre B, Mandelbrot L, Petrucciani N, Quilliot D, Ritz P, Robin G, Sallé A, Gugenheim J, Nizard J, BARIA-MAT Group.

doi: 10.1007/

Related content